PAPER Eldeeb M, Hohman G, Shahid M
SEARCH RESULTS
343299 RESULTS
David Schmidt
, Germany
PAPER Sanyal A, Scanavachi G, Somerville E, Saminathan A, Nair A, Bango Da Cunha Correia RF, Aylan B, Sitarska E, Oikonomou A, Hatzakis NS, Kirchhausen T
Neuronal constitutive endolysosomal perforations enable α-synuclein aggregation by internalized PFFs.
J Cell Biol. 2025 Feb 3;224(2) Epub 2024 Dec 23 PubMed.PAPER Yoshida K, Forrest SL, Ichimata S, Tanaka H, Kon T, Kovacs GG
Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases.
Alzheimers Dement. 2024 Dec 23; Epub 2024 Dec 23 PubMed.PAPER de Mena L, Parés G, Garrido A, Pilco-Janeta DF, Fernández M, Pérez J, Tolosa E, Cámara A, Valldeoriola F, Ezquerra M, Martí MJ, Fernández-Santiago R, Barcelona LRRK2 Study Group
α-Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients.
Mov Disord. 2024 Dec 23; Epub 2024 Dec 23 PubMed.PAPER Olivares Ordoñez MA, Smith RC, Yiu G, Liu YA
Retinal Microstructural and Microvascular Changes in Alzheimer Disease: A Review.
Int Ophthalmol Clin. 2025 Jan 1;65(1):59-67. Epub 2024 Dec 23 PubMed.PAPER Qiao M, Wu H, Chi L, Yao Q, Qi X, Ye X, Lin X, Tian M
A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.
BMC Neurol. 2024 Dec 23;24(1):489. PubMed.PAPER Sun J, Shen A, Sun Y, Chen X, Li Y, Gao X, Lu B
Adaptive spatiotemporal encoding network for cognitive assessment using resting state EEG.
NPJ Digit Med. 2024 Dec 23;7(1):375. PubMed.PAPER
Erratum: Tosi et al., "The Network Structure of Cognitive Impairment: From Subjective Cognitive Decline to Alzheimer's Disease".
J Neurosci. 2024 Dec 23; Epub 2024 Dec 23 PubMed. Corrected paper.PAPER Lee GB, Jeong YJ, Kang DY, Yun HJ, Yoon M
Multimodal feature fusion-based graph convolutional networks for Alzheimer's disease stage classification using F-18 florbetaben brain PET images and clinical indicators.
PLoS One. 2024;19(12):e0315809. Epub 2024 Dec 23 PubMed.PAPER Liu X, Wu W, Li X, Wang C, Chai K, Yuan F, Zheng H, Yao Y, Li C, Ye ZC, Zha D
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease.
Neural Regen Res. 2025 Nov 1;20(11):3330-3344. Epub 2024 Jul 10 PubMed.PAPER Alagiakrishnan K, Halverson T, Ahmed A, Frishman WH, Aronow WS
Hypertension and Cognitive Disorders.
Cardiol Rev. 2024 Dec 23; Epub 2024 Dec 23 PubMed.PAPER Battineni G, Chintalapudi N, Amenta F
Machine Learning Driven by Magnetic Resonance Imaging for the Classification of Alzheimer Disease Progression: Systematic Review and Meta-Analysis.
JMIR Aging. 2024 Dec 23;7:e59370. PubMed.PAPER Dickerson BC, Atri A, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M
The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.
Alzheimers Dement. 2024 Dec 23; Epub 2024 Dec 23 PubMed.PAPER Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M
Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care.
Alzheimers Dement. 2024 Dec 23; Epub 2024 Dec 23 PubMed.Current Filters
No filters selected